Line 9: |
Line 9: |
| | | |
| == Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms == | | == Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms == |
− | *[[Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities]] | + | *[[Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities|AML with Recurrent Genetic Abnormalities]] |
| | | |
− | - [[Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1]] | + | - [[Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1|AML with t(8;21)(q22;q22.1); RUNX1-RUNX1T1]] |
− | - [[Acute Myeloid Leukemia (AML) with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11]] | + | - [[Acute Myeloid Leukemia (AML) with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11|AML with with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11]] |
| - [[Acute Promyelocytic Leukemia (APL) with PML-RARA]] | | - [[Acute Promyelocytic Leukemia (APL) with PML-RARA]] |
− | - [[Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3]] | + | - [[Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3|AML with t(9;11)(p21.3;q23.3); KMT2A-MLLT3]] |
− | - [[Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214]] | + | - [[Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214|AML with t(6;9)(p23;q34.1); DEK-NUP214]] |
− | - [[Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM]] | + | - [[Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM|AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM]] |
− | - [[Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1]] | + | - [[Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1|AML Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1]] |
− | - [[Acute Myeloid Leukemia (AML) with BCR-ABL1]] | + | - [[Acute Myeloid Leukemia (AML) with BCR-ABL1|AML with BCR-ABL1]] |
− | - [[Acute Myeloid Leukemia (AML) with Mutated NPM1]] | + | - [[Acute Myeloid Leukemia (AML) with Mutated NPM1|AML with Mutated NPM1]] |
− | - [[Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA]] | + | - [[Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA|AML with Biallelic Mutations of CEBPA]] |
− | - [[Acute Myeloid Leukemia (AML) with Mutated RUNX1]] | + | - [[Acute Myeloid Leukemia (AML) with Mutated RUNX1|AML with Mutated RUNX1]] |
| | | |
− | *[[Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes]] | + | *[[Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes|AML with Myelodysplasia-Related Changes]] |
| | | |
| *[[Therapy-Related Myeloid Neoplasms]] | | *[[Therapy-Related Myeloid Neoplasms]] |